CI
JUNO

Capital International’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital International’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-69,400
Closed -$3.17M – 176
2017
Q4 		$3.17M Sell
69,400
-260,000
-79% -$13M 0.6% 57
2017
Q3 		$14.8M Buy
+329,400
New +$11.2M 0.98% 44

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capital International's JUNO Position: Q1 2018 in Review

Capital International sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 69,400 shares — an estimated $3.17M sold.

Capital International first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $14.8M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital International reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital International sold 69,400 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3.17M.
  • Capital International first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital International's Juno Therapeutics, Inc. position peaked at $14.8M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital International's 13F filing for Q1 2018, filed 15 May 2018.